Chinese Biopharma Henlius: Layout, Product Competitiveness and Performance Under Globalisation 2.0
Antibody engineering, immunotherapy and AI-driven drug discovery continue to reshape global biopharma. More Asian biotech companies are clearing strict international quality audits and building overseas sales capabilities. Henlius (2696.HK), headquartered in Shanghai, China,is a global biopharmaceutical company developing both biosimilars and innovative biologics, while building integrated capabilities across R&D, clinical development,regulatory affairs, manufacturing and commercialisation…
